An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Clinical trial NCT02675998 · COMPLETED
Trial details
- NCT number
- NCT02675998
- Sponsor
- Ardelyx
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2016-12-01
- Enrollment
- 219
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.